BBIO Q2 2020 Earnings — BridgeBio Pharma, Inc. Revenue & Financial Results | Market Cap Arena

BBIOBridgeBio Pharma, Inc.

$14B

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$125M

Net Income

-$121M

EPS (Diluted)

$-1.03

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$88M

Free Cash Flow

-$88M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$905M

Total Liabilities

$578M

Stockholders' Equity

$266M

Cash & Equivalents

$541M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$125M	-$69M	-79.7%
Net Income	-$121M	-$66M	-83.7%